SOC Telemed, Inc.
TLMDDelisted Apr 6, 2022- Industry
- Services-Misc Health & Allied Services, NEC
- SEC CIK
- 0001791091
SOC Telemed, Inc. was delisted on Apr 6, 2022; its insiders filed their last Form 4 on Apr 7, 2022; 81 institutions reported holding it in 13F filings for Q1 2022, worth $188.2M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by SOC Telemed, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for SOC Telemed, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Warburg Pincus & Co. | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| Warburg Pincus Private Equity XI, L.P. | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| Warburg Pincus XI, L.P. | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| WP Global LLC | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| Warburg Pincus XI Partners, L.P. | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| Warburg Pincus Partners GP LLC | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| Warburg Pincus Partners II, L.P. | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| WPXI Finance, LP | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| Wpxi GP, L.P. | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| SOC Holdings LLC | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| Warburg Pincus LLC | Director, 10% Owner | 0Indirect | Apr 7, 2022 | 0 |
| Shulman Steven J | Other: Former Director | 0 | Apr 7, 2022 | 0 |
| Fletcher David R. | Other: Former Interim CFO | – | Apr 7, 2022 | 0 |
| Carella Thomas J. | Other: Former Director | 0 | Apr 7, 2022 | 0 |
| Greskoviak Joseph P | Other: Former Director | 0 | Apr 7, 2022 | 0 |
| Kronfol Amr | Other: Former Director | 0 | Apr 7, 2022 | 0 |
| McGeorge Anne | Other: Former Director | 0 | Apr 7, 2022 | 0 |
| Byrne Barbara Peterson | Other: Former Director | 0 | Apr 7, 2022 | 0 |
| Hallock Robert Jason | Chief Medical Officer | 0 | Apr 7, 2022 | 0 |
| Kim Eunice | General Counsel | 0 | Apr 7, 2022 | 0 |
| Gallagher Christopher M. | Chief Executive Officer | 0Indirect | Apr 7, 2022 | 0 |
| Chisley Gyasi C. | Other: Former Director | 0 | Apr 7, 2022 | 0 |
| Mikula David | Chief Operating Officer | 0 | Apr 7, 2022 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 4, 2022 (view filing) | Apr 1 | 3 days | Hallock Robert JasonChief Medical Officer | SSaleClass A Common Stock | −6.49K | $2.98 | −$19.3K | −7.3%82.2K after |